Join
Live feed
·
INSIDERFilingvia Quantisnow
Intra-Cellular Therapies Inc. logo

Mates Sharon sold $4,048,400 worth of shares (61,277 units at $66.07) and converted options into 20,565 shares, decreasing direct ownership by 4% to 1,050,309 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ITCI· Intra-Cellular Therapies Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITCI (Intra-Cellular Therapies Inc.) and more on Quantisnow.